Differences in Clinical Characteristics Between Delta Variant and Wild-Type SARS-CoV-2 Infected Patients
出版年份 2022 全文链接
标题
Differences in Clinical Characteristics Between Delta Variant and Wild-Type SARS-CoV-2 Infected Patients
作者
关键词
-
出版物
Frontiers in Medicine
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-01-03
DOI
10.3389/fmed.2021.792135
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Mutation rates and selection on synonymous mutations in SARS-CoV-2
- (2021) Nicola De Maio et al. Genome Biology and Evolution
- Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries
- (2021) Rui Wang et al. GENOMICS
- Identification of a SARS-CoV-2 Variant with L452R and E484Q Neutralization Resistance Mutations
- (2021) Michelle Verghese et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Spike mutation T478K
- (2021) Simone Di Giacomo et al. JOURNAL OF MEDICAL VIROLOGY
- Comprehensive large-scale nucleic acid–testing strategies support China’s sustained containment of COVID-19
- (2021) Zhongjie Li et al. NATURE MEDICINE
- Novel coronavirus disease 2019 (COVID-19) pandemic: From transmission to control with an interdisciplinary vision
- (2021) Uttpal Anand et al. ENVIRONMENTAL RESEARCH
- Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021
- (2021) Jeromie Wesley Vivian Thangaraj et al. JOURNAL OF INFECTION
- SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion
- (2021) Isabella A T M Ferreira et al. JOURNAL OF INFECTIOUS DISEASES
- Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study
- (2021) Michela Antonelli et al. LANCET INFECTIOUS DISEASES
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
- (2021) Delphine Planas et al. NATURE
- The mutation that helps Delta spread like wildfire
- (2021) Ewen Callaway NATURE
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
- (2021) Jamie Lopez Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce
- (2021) Jocelyn Keehner et al. NEW ENGLAND JOURNAL OF MEDICINE
- The total number and mass of SARS-CoV-2 virions
- (2021) Ron Sender et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Covid-19: How many variants are there, and what do we know about them?: Video 1
- (2021) Elisabeth Mahase BMJ-British Medical Journal
- Lifting of COVID-19 restrictions in the UK and the Delta variant
- (2021) Talha Khan Burki Lancet Respiratory Medicine
- SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
- (2021) Daniel Martínez-Flores et al. Frontiers in Immunology
- Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update
- (2021) Uttpal Anand et al. Frontiers in Immunology
- SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse
- (2021) Frank Konings et al. Nature Microbiology
- Comparative Study of Acute Lung Injury in COVID-19 and Non-COVID-19 Patients
- (2021) Jianguo Zhang et al. Frontiers in Medicine
- Platelet-driven coagulopathy in COVID-19 patients: in comparison to seasonal influenza cases
- (2021) Jianguo Zhang et al. Experimental Hematology & Oncology
- The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
- (2021) Elisa Teyssou et al. JOURNAL OF INFECTION
- Covid-19: Molnupiravir reduces risk of hospital admission or death by 50% in patients at risk, MSD reports
- (2021) Elisabeth Mahase BMJ-British Medical Journal
- Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?
- (2021) Varda Shoshan-Barmatz et al. Frontiers in Physiology
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study
- (2020) Heshui Shi et al. LANCET INFECTIOUS DISEASES
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Traditional Chinese Medicine for COVID-19 Treatment
- (2020) Jun-ling Ren et al. PHARMACOLOGICAL RESEARCH
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
- (2020) Michael Letko et al. Nature Microbiology
- The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade
- (2020) B. Coutard et al. ANTIVIRAL RESEARCH
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
- (2020) James M. Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Differentiation of COVID‐19 from seasonal influenza: A multicenter comparative study
- (2020) Jianguo Zhang et al. JOURNAL OF MEDICAL VIROLOGY
- The coding capacity of SARS-CoV-2
- (2020) Yaara Finkel et al. NATURE
- Temporal signal and the phylodynamic threshold of SARS-CoV-2
- (2020) Sebastian Duchene et al. Virus Evolution
- Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
- (2020) Erik Volz et al. CELL
- Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19
- (2020) Eric J. Lenze et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- (2020) Yanjun Zhang et al. LANCET INFECTIOUS DISEASES
- Structure, Function, and Evolution of Coronavirus Spike Proteins
- (2016) Fang Li Annual Review of Virology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started